Patents by Inventor Meenakshi GAUR

Meenakshi GAUR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220370503
    Abstract: Provided herein are methods and devices related to inducing a population of self-renewing or senescent stem cells, to produce one or more beneficial factors for the treatment of a disease or disorder in an individual. Also provided are compositions and methods for inducing senescence, useful for inducing senescence in a population of stem cells, in order to produce one or more beneficial factors for the treatment of a disease or disorder in an individual. Methods and devices to control and customize the production of the beneficial factors for the requirements of a disease or disorder being treated are described. Also provided are factor production units for the production of the beneficial factors, and devices for the delivery of the beneficial factors to an individual in need.
    Type: Application
    Filed: March 31, 2022
    Publication date: November 24, 2022
    Inventors: Victoria LUNYAK, Meenakshi GAUR
  • Patent number: 11291689
    Abstract: Provided herein are methods and devices related to inducing a population of self-renewing or senescent stem cells, to produce one or more beneficial factors for the treatment of a disease or disorder in an individual. Also provided are compositions and methods for inducing senescence, useful for inducing senescence in a population of stem cells, in order to produce one or more beneficial factors for the treatment of a disease or disorder in an individual. Methods and devices to control and customize the production of the beneficial factors for the requirements of a disease or disorder being treated are described. Also provided are factor production units for the production of the beneficial factors, and devices for the delivery of the beneficial factors to an individual in need.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: April 5, 2022
    Assignee: AELAN CELL TECHNOLOGIES, INC.
    Inventors: Victoria Lunyak, Meenakshi Gaur
  • Patent number: 11293065
    Abstract: Provided herein are methods and compositions for assessing the quality and potential of stem cells in a sample. Such methods and compositions are useful for helping to ensure the safety and quality of a population of stem cells before it is used in a subject.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: April 5, 2022
    Assignee: AELAN CELL TECHNOLOGIES, INC.
    Inventors: Victoria Lunyak, Meenakshi Gaur
  • Patent number: 11179439
    Abstract: Provided herein are methods and compositions for preventing and treating damage to the heart subsequent to myocardial infarction (MI) resulting from harmful fibrotic remodeling, thereby improving cardiac function and reducing mortality from subsequent heart failure.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: November 23, 2021
    Assignees: MandalMed, Inc., The Regents of the University of California
    Inventors: Constance M. John, Meenakshi Gaur, Matthew L. Springer, Xiaoyin Wang
  • Publication number: 20200246427
    Abstract: Provided herein are methods and compositions for preventing and treating damage to the heart subsequent to myocardial infarction (MI) resulting from harmful fibrotic remodeling, thereby improving cardiac function and reducing mortality from subsequent heart failure.
    Type: Application
    Filed: June 18, 2019
    Publication date: August 6, 2020
    Applicants: MandalMed, Inc., The Regents of the University of California
    Inventors: Constance M. JOHN, Meenakshi GAUR, Matthew L. SPRINGER, Xiaoyin WANG
  • Publication number: 20190241958
    Abstract: Provided herein are methods and compositions for assessing the quality and potential of stem cells in a sample. Such methods and compositions are useful for helping to ensure the safety and quality of a population of stem cells before it is used in a subject.
    Type: Application
    Filed: March 14, 2017
    Publication date: August 8, 2019
    Inventors: Victoria LUNYAK, Meenakshi GAUR
  • Patent number: 10369195
    Abstract: Provided herein are methods and compositions for preventing and treating damage to the heart subsequent to myocardial infarction (MI) resulting from harmful fibrotic remodeling, thereby improving cardiac function and reducing mortality from subsequent heart failure.
    Type: Grant
    Filed: August 1, 2017
    Date of Patent: August 6, 2019
    Assignees: MandalMed, Inc., The Regents of the University of California
    Inventors: Constance M. John, Meenakshi Gaur, Matthew L. Springer, Xiaoyin Wang
  • Publication number: 20180161373
    Abstract: Provided herein are methods and devices related to inducing a population of self-renewing or senescent stem cells, to produce one or more beneficial factors for the treatment of a disease or disorder in an individual. Also provided are compositions and methods for inducing senescence, useful for inducing senescence in a population of stem cells, in order to produce one or more beneficial factors for the treatment of a disease or disorder in an individual. Methods and devices to control and customize the production of the beneficial factors for the requirements of a disease or disorder being treated are described. Also provided are factor production units for the production of the beneficial factors, and devices for the delivery of the beneficial factors to an individual in need.
    Type: Application
    Filed: June 2, 2016
    Publication date: June 14, 2018
    Inventors: Victoria LUNYAK, Meenakshi GAUR
  • Publication number: 20180136209
    Abstract: Described herein are companion methods and kits useful for IL-2-based therapies and for mesenchymal stem cell-based therapies.
    Type: Application
    Filed: June 2, 2016
    Publication date: May 17, 2018
    Inventors: Victoria LUNYAK, Meenakshi GAUR
  • Publication number: 20180042993
    Abstract: Provided herein are methods and compositions for preventing and treating damage to the heart subsequent to myocardial infarction (MI) resulting from harmful fibrotic remodeling, thereby improving cardiac function and reducing mortality from subsequent heart failure.
    Type: Application
    Filed: August 1, 2017
    Publication date: February 15, 2018
    Inventors: Constance M. JOHN, Meenakshi GAUR, Matthew L. SPRINGER, Xiaoyin WANG